For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

Their report discusses the tensions between the TRIPS Agreement and International Human Rights Law as they apply to pharmaceuticals, and how those tensions have played out in the COVID-19 pandemic. They identify some opportunities for systemic integration, and ask questions about the unsolved issues around states’ extraterritorial human rights obligations and pharmaceutical companies’ responsibilities.

Their report was one in a series of reports, commissioned under the theme ‘Global Health Law Disrupted: Covid-19 and the Climate Crisis’. 

Katrina Perehudoff would like to thank Prof. Em. Willem van Genugten, Prof. Brigit Toebes and her co-authors.

Dr. S.K. (Katrina) Perehudoff

Faculty of Law

Gezondheidsrecht